174 related articles for article (PubMed ID: 9732069)
1. Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.
Derouin F; Gérard L; Farinotti R; Maslo C; Leport C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):50-4. PubMed ID: 9732069
[TBL] [Abstract][Full Text] [Related]
2. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
Araujo FG; Suzuki Y; Remington JS
Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
[TBL] [Abstract][Full Text] [Related]
4. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
[TBL] [Abstract][Full Text] [Related]
5. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
Li Y; Zeng YM; Lu YQ; Qin YY; Chen YK
Medicine (Baltimore); 2020 May; 99(20):e20146. PubMed ID: 32443329
[TBL] [Abstract][Full Text] [Related]
6. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
8. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
[TBL] [Abstract][Full Text] [Related]
10. [Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
Langmann P; Klinker H; Richter E
Dtsch Med Wochenschr; 1995 May; 120(21):780-1. PubMed ID: 7781508
[No Abstract] [Full Text] [Related]
11. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.
Dannemann B; McCutchan JA; Israelski D; Antoniskis D; Leport C; Luft B; Nussbaum J; Clumeck N; Morlat P; Chiu J
Ann Intern Med; 1992 Jan; 116(1):33-43. PubMed ID: 1727093
[TBL] [Abstract][Full Text] [Related]
12. Empiric treatment of acute Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
Iribarren JA; Arrizabalaga J; Garde C; Rodriguez-Arrondo F; Blanco A
Arch Intern Med; 1992 Oct; 152(10):2139-40. PubMed ID: 1417389
[No Abstract] [Full Text] [Related]
13. Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome.
Van Delden C; Hirschel B
J Infect Dis; 1996 May; 173(5):1294-5. PubMed ID: 8627092
[No Abstract] [Full Text] [Related]
14. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
[TBL] [Abstract][Full Text] [Related]
15. Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS.
Saba J; Morlat P; Raffi F; Hazebroucq V; Joly V; Leport C; Vildé JL
Eur J Clin Microbiol Infect Dis; 1993 Nov; 12(11):853-6. PubMed ID: 8112357
[TBL] [Abstract][Full Text] [Related]
16. Toxoplasmosis in AIDS: keeping the lid on.
Kovacs JA
Ann Intern Med; 1995 Aug; 123(3):230-1. PubMed ID: 7598306
[No Abstract] [Full Text] [Related]
17. Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine.
Sina S; Mohammad JM; Reza S; Anita M; Soudabeh E; Hadi M
Eur J Med Res; 2021 Jun; 26(1):65. PubMed ID: 34193287
[TBL] [Abstract][Full Text] [Related]
18. AIDS commentary. Toxoplasmic encephalitis.
Luft BJ; Remington JS
J Infect Dis; 1988 Jan; 157(1):1-6. PubMed ID: 3121758
[No Abstract] [Full Text] [Related]
19. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis.
Caumes E; Bocquet H; Guermonprez G; Rogeaux O; Bricaire F; Katlama C; Gentilini M
Clin Infect Dis; 1995 Sep; 21(3):656-8. PubMed ID: 8527561
[TBL] [Abstract][Full Text] [Related]
20. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Podzamczer D; Miró JM; Bolao F; Gatell JM; Cosín J; Sirera G; Domingo P; Laguna F; Santamaría J; Verdejo J
Ann Intern Med; 1995 Aug; 123(3):175-80. PubMed ID: 7598298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
